SEC Form 4 · accession 0001104659-15-083972
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Elsbree
Director
Period of report
Dec 9, 2015
Accepted (ET)
Dec 10, 2015 · 11:07 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 9, 2015 | P | 10,000 | $9.75 | A | 30,000 | D | |
| Common StockF1 | holding | — | — | — | 4,275 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $10.70 | Dec 8, 2015 | G | 22,222 | D | — | Jul 2, 2024 | Common Stock | 22,222 | 27,778 | D |
| Employee Stock Option (right to buy)F3 | $10.70 | Dec 8, 2015 | G | 7,189 | D | — | Jul 19, 2024 | Common Stock | 7,189 | 8,987 | D |
| Employee Stock Option (right to buy)F4 | $18.59 | Dec 8, 2015 | G | 5,882 | D | — | Jun 19, 2025 | Common Stock | 5,882 | 11,765 | D |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F2This Stock Option was granted on July 2, 2014 and vests in 36 equal monthly installments beginning on the grant date
- F3This Stock Option was granted on July 19, 2013 and vests in 36 equal monthly installments beginning on the grant date.
- F4The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 19, 2015.